Sameer A. Ansari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sameer A. Ansari has a total of 314 co-authors. Here are the top co-authors by number of shared publications:
- Ali Shaibani
Department of Radiology, Ann and Robert H. Lurie Children’s Hospital of Chicago, IL (A.S.).
15 shared publications - Babak S. Jahromi
Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, IL (B.J.).
13 shared publications - Matthew Bryan Potts
Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
12 shared publications - Ramez Nader Abdalla
Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
12 shared publications - Michael C. Hurley
Department of Radiology (M.C.H.), University of Chicago, Chicago, Illinois
11 shared publications - Donald Robert Cantrell
Department of Radiology Northwestern University, Feinberg School of Medicine Chicago Illinois USA
7 shared publications
Latest Publications
- 30 October 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Suspected Segmental Arterial Mediolysis with Spinal Subarachnoid Hemorrhage and Mesenteric Aneurysms
Segmental arterial mediolysis (SAM) rarely involves spinal vasculature. A 63-year-old woman with muscle-invasive urothelial bladder cancer developed acute abdominal and lower back pain 2 days after cisplatin and 3 days after gemcitabine chemotherapy. CT showed a small omental infarct, and spinal MRI demonstrated extensive thoracolumbar intraspinal hemorrhage. Spinal angiography revealed a left C5 radiculomedullary aneurysm. Repeat angiography 1 week later showed a stable C5 aneurysm and demonstrated two tandem anterior spinal artery aneurysms. Concurrent selective superior mesenteric artery angiography showed multifocal stenoses and fusiform branch aneurysms with main-trunk corrugation. The angiographic pattern favored a working diagnosis of SAM, although fibromuscular dysplasia and treatment-associated vasculitis remained considerations. No definite culprit spinal aneurysm was identified. Because intervention involved critical spinal arterial supply, the lesions were managed conservatively. Follow-up imaging over 11 months showed spinal hemorrhage resorption and near-resolution of the mesenteric aneurysms, with only a residual submillimeter anterior spinal artery aneurysm.
- 30 October 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Suspected Segmental Arterial Mediolysis with Spinal Subarachnoid Hemorrhage and Mesenteric Aneurysms
Segmental arterial mediolysis (SAM) rarely involves spinal vasculature. A 63-year-old woman with muscle-invasive urothelial bladder cancer developed acute abdominal and lower back pain 2 days after cisplatin and 3 days after gemcitabine chemotherapy. CT showed a small omental infarct, and spinal MRI demonstrated extensive thoracolumbar intraspinal hemorrhage. Spinal angiography revealed a left C5 radiculomedullary aneurysm. Repeat angiography 1 week later showed a stable C5 aneurysm and demonstrated two tandem anterior spinal artery aneurysms. Concurrent selective superior mesenteric artery angiography showed multifocal stenoses and fusiform branch aneurysms with main-trunk corrugation. The angiographic pattern favored a working diagnosis of SAM, although fibromuscular dysplasia and treatment-associated vasculitis remained considerations. No definite culprit spinal aneurysm was identified. Because intervention involved critical spinal arterial supply, the lesions were managed conservatively. Follow-up imaging over 11 months showed spinal hemorrhage resorption and near-resolution of the mesenteric aneurysms, with only a residual submillimeter anterior spinal artery aneurysm.
- Open Access
- 22 October 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (12) , e70426
Whole‐Brain 4D MRA With Improved Vessel Delineation Using Undersampled Multiple Overlapping Thin‐Slab Radial Acquisition
Time‐resolved arterial spin labeling (ASL)‐based noncontrast 4D MRA enables visualization of cerebral arterial flow dynamic patterns and holds great potential for evaluating cerebrovascular disease. However, conventional ASL 4D MRA implementations using look‐locker acquisitions are susceptible to progressive RF saturation during extended readouts, leading to substantial ASL signal attenuation and loss of vessel delineation in distal arteries. These limitations potentially hinder a wider clinical translation of 4D MRA, especially when assessment of whole‐brain vascular anatomy and flow dynamics is needed. This study introduces a practical and reliable ASL 4D MRA technique for whole‐brain or large volumetric imaging by integrating pulsed ASL with undersampled multiple overlapping thin‐slab stack‐of‐stars (SOS) golden‐angle radial acquisition. The proposed method was evaluated against conventional single‐slab 4D MRA, 3D time‐of‐flight magnetic resonance angiography (TOF‐MRA), and pseudocontinuous ASL (pCASL)‐based 4D MRA in terms of vessel delineation, blood flow dynamics, and image quality. Compared to the other methods, the proposed method substantially reduced RF saturation effects and preserved signal intensities in distal small arteries, resulting in significantly improved vessel continuity and contrast throughout the cerebral vasculature, as well as reliably capturing complete inflow‐to‐outflow arterial flow dynamics with good scan efficiency and image quality. The proposed technique enables high‐quality, time‐resolved whole‐brain angiography, offering a promising noncontrast imaging tool for comprehensive assessment of cerebral arterial hemodynamics in clinical and research applications.
- 22 October 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (12) , e70426
Open AccessWhole‐Brain 4D MRA With Improved Vessel Delineation Using Undersampled Multiple Overlapping Thin‐Slab Radial Acquisition
Time‐resolved arterial spin labeling (ASL)‐based noncontrast 4D MRA enables visualization of cerebral arterial flow dynamic patterns and holds great potential for evaluating cerebrovascular disease. However, conventional ASL 4D MRA implementations using look‐locker acquisitions are susceptible to progressive RF saturation during extended readouts, leading to substantial ASL signal attenuation and loss of vessel delineation in distal arteries. These limitations potentially hinder a wider clinical translation of 4D MRA, especially when assessment of whole‐brain vascular anatomy and flow dynamics is needed. This study introduces a practical and reliable ASL 4D MRA technique for whole‐brain or large volumetric imaging by integrating pulsed ASL with undersampled multiple overlapping thin‐slab stack‐of‐stars (SOS) golden‐angle radial acquisition. The proposed method was evaluated against conventional single‐slab 4D MRA, 3D time‐of‐flight magnetic resonance angiography (TOF‐MRA), and pseudocontinuous ASL (pCASL)‐based 4D MRA in terms of vessel delineation, blood flow dynamics, and image quality. Compared to the other methods, the proposed method substantially reduced RF saturation effects and preserved signal intensities in distal small arteries, resulting in significantly improved vessel continuity and contrast throughout the cerebral vasculature, as well as reliably capturing complete inflow‐to‐outflow arterial flow dynamics with good scan efficiency and image quality. The proposed technique enables high‐quality, time‐resolved whole‐brain angiography, offering a promising noncontrast imaging tool for comprehensive assessment of cerebral arterial hemodynamics in clinical and research applications.
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (3)
RNS60 RESCUE Trial in Acute Ischemic Stroke: Post Hoc Analysis in Participants Enrolled <12 Hours Since Last Known Well
BACKGROUND: Adjunct therapies are needed for patients with acute ischemic stroke who fare poorly, despite standard-of-care endovascular thrombectomy (EVT). RESCUE (A Randomized, Blinded, Placebo-Controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy) tested the cytoprotective experimental drug RNS60 in patients with acute ischemic stroke, adjunct to EVT with or without prior standard-of-care thrombolytic treatment. METHODS: RESCUE, a randomized, placebo-controlled, double-blind, phase 2 study, enrolled 83 participants eligible for EVT within 24 hours since last known well, assigned 1:1:1 to 48-hour infusion of RNS60 0.5 mL/kg per hour, RNS60 1.0 mL/kg per hour, or placebo 1.0 mL/kg per hour. A post hoc analysis evaluated safety and efficacy in a subpopulation of 62 participants enrolled within 12 hours since last known well. Efficacy end points included modified Rankin Scale score, post-EVT infarct growth, National Institutes of Health Stroke Scale score, Barthel Index score, EuroQoL, and duration of hospitalization and discharge disposition. RESULTS: In this subpopulation, RNS60 1.0 mL/kg per hour was generally safe and well tolerated and reduced post-EVT infarct growth compared with placebo (least squares mean difference, 22.2; P =0.05). Of the participants treated with RNS60 1.0 mL/kg per hour, 72.2% achieved a 90-day modified Rankin Scale score of 0 to 2, and 72.2% achieved a Barthel Index score ≥95, compared with 36.8% (for both measures) of those receiving placebo, although the differences were not statistically significant ( P =0.09 for both modified Rankin Scale and Barthel Index scores). Consistent but smaller differences to placebo were seen in the RNS60 0.5 mL/kg per hour group, which suggests a dose-dependent effect of RNS60. Participants in the RNS60 1.0 mL/kg per hour group were also released earlier from the hospital than those in the placebo group (mean [SD]: 6.0 [5.10] days versus 10.8 [6.84] days; mean difference [SE], −4.8 [1.99]; P =0.02). Final infarct volumes at 48 hours post-EVT correlated with modified Rankin Scale scores at day 90 for RNS60 1.0 mL/kg per (Pearson r =0.65; P =0.005) and placebo ( r =0.65; P =0.007). CONCLUSIONS: Effects of RNS60 were favorable compared with placebo in the analyzed subpopulation, warranting further investigation in this population. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04693715.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (3)
Open AccessRNS60 RESCUE Trial in Acute Ischemic Stroke: Post Hoc Analysis in Participants Enrolled <12 Hours Since Last Known Well
BACKGROUND: Adjunct therapies are needed for patients with acute ischemic stroke who fare poorly, despite standard-of-care endovascular thrombectomy (EVT). RESCUE (A Randomized, Blinded, Placebo-Controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy) tested the cytoprotective experimental drug RNS60 in patients with acute ischemic stroke, adjunct to EVT with or without prior standard-of-care thrombolytic treatment. METHODS: RESCUE, a randomized, placebo-controlled, double-blind, phase 2 study, enrolled 83 participants eligible for EVT within 24 hours since last known well, assigned 1:1:1 to 48-hour infusion of RNS60 0.5 mL/kg per hour, RNS60 1.0 mL/kg per hour, or placebo 1.0 mL/kg per hour. A post hoc analysis evaluated safety and efficacy in a subpopulation of 62 participants enrolled within 12 hours since last known well. Efficacy end points included modified Rankin Scale score, post-EVT infarct growth, National Institutes of Health Stroke Scale score, Barthel Index score, EuroQoL, and duration of hospitalization and discharge disposition. RESULTS: In this subpopulation, RNS60 1.0 mL/kg per hour was generally safe and well tolerated and reduced post-EVT infarct growth compared with placebo (least squares mean difference, 22.2; P =0.05). Of the participants treated with RNS60 1.0 mL/kg per hour, 72.2% achieved a 90-day modified Rankin Scale score of 0 to 2, and 72.2% achieved a Barthel Index score ≥95, compared with 36.8% (for both measures) of those receiving placebo, although the differences were not statistically significant ( P =0.09 for both modified Rankin Scale and Barthel Index scores). Consistent but smaller differences to placebo were seen in the RNS60 0.5 mL/kg per hour group, which suggests a dose-dependent effect of RNS60. Participants in the RNS60 1.0 mL/kg per hour group were also released earlier from the hospital than those in the placebo group (mean [SD]: 6.0 [5.10] days versus 10.8 [6.84] days; mean difference [SE], −4.8 [1.99]; P =0.02). Final infarct volumes at 48 hours post-EVT correlated with modified Rankin Scale scores at day 90 for RNS60 1.0 mL/kg per (Pearson r =0.65; P =0.005) and placebo ( r =0.65; P =0.007). CONCLUSIONS: Effects of RNS60 were favorable compared with placebo in the analyzed subpopulation, warranting further investigation in this population. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04693715.
- Open Access
- 16 March 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Uncertainty-aware automated labeling of intracranial arteries using deep learning
Background: Accurate anatomical labeling of intracranial arteries is critical for cerebrovascular diagnosis and hemodynamic analysis, but remains time-consuming and prone to inter-operator variability. While deep learning provides an automated solution, its clinical adoption is limited by the lack of confidence measures. Incorporating uncertainty quantification into automated labeling could enhance interpretability by identifying ambiguous or abnormal regions and support clinical trust, yet this aspect remains underexplored. Methods: To address this gap, we introduce an uncertainty-aware deep learning framework for automated artery labeling from 3D Time-of-Flight Magnetic Resonance Angiography (3D ToF-MRA) segmentations ( n = 35). Three convolutional neural network architectures were evaluated: (1) UNet with residual encoder blocks, (2) CS-Net, an attention-augmented UNet with spatial attention, and (3) nnUNet, a self-configuring framework that adapts architecture and training to dataset characteristics. Confidence was modeled via test-time augmentation (TTA) combined with a novel coordinate-guided strategy to reduce interpolation errors during inference. Generalizability was assessed by evaluating a subset of the public TubeTK ToF-MRA dataset ( n = 20). Results: Voxelwise uncertainty maps highlighted anatomical ambiguities, pathological variations, and inconsistencies in manual references, providing intuitive confidence indicators. nnUNet achieved the highest performance (average Dice score 0.93; clDice 0.94; average surface distance 0.35 mm; 95th percentile of Hausdorff distance 4.51 mm), demonstrating robustness in complex vascular regions. On the TubeTK dataset, nnUNet maintained robust generalization (average Dice score 0.87; clDice 0.87; average surface distance 0.42 mm; 95th percentile of Hausdorff distance 5.85 mm). Validation against co-registered 4D flow MRI showed close agreement between flow velocities derived from automated and manual labels, with no significant differences. Conclusion: The proposed framework delivers a scalable, accurate, and uncertainty-aware solution for intracranial artery labeling. By integrating uncertainty quantification, it offers a transparent and clinically trustworthy tool to facilitate cerebrovascular imaging workflows and support subsequent hemodynamic analyses.
- 16 March 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Open AccessUncertainty-aware automated labeling of intracranial arteries using deep learning
Background: Accurate anatomical labeling of intracranial arteries is critical for cerebrovascular diagnosis and hemodynamic analysis, but remains time-consuming and prone to inter-operator variability. While deep learning provides an automated solution, its clinical adoption is limited by the lack of confidence measures. Incorporating uncertainty quantification into automated labeling could enhance interpretability by identifying ambiguous or abnormal regions and support clinical trust, yet this aspect remains underexplored. Methods: To address this gap, we introduce an uncertainty-aware deep learning framework for automated artery labeling from 3D Time-of-Flight Magnetic Resonance Angiography (3D ToF-MRA) segmentations ( n = 35). Three convolutional neural network architectures were evaluated: (1) UNet with residual encoder blocks, (2) CS-Net, an attention-augmented UNet with spatial attention, and (3) nnUNet, a self-configuring framework that adapts architecture and training to dataset characteristics. Confidence was modeled via test-time augmentation (TTA) combined with a novel coordinate-guided strategy to reduce interpolation errors during inference. Generalizability was assessed by evaluating a subset of the public TubeTK ToF-MRA dataset ( n = 20). Results: Voxelwise uncertainty maps highlighted anatomical ambiguities, pathological variations, and inconsistencies in manual references, providing intuitive confidence indicators. nnUNet achieved the highest performance (average Dice score 0.93; clDice 0.94; average surface distance 0.35 mm; 95th percentile of Hausdorff distance 4.51 mm), demonstrating robustness in complex vascular regions. On the TubeTK dataset, nnUNet maintained robust generalization (average Dice score 0.87; clDice 0.87; average surface distance 0.42 mm; 95th percentile of Hausdorff distance 5.85 mm). Validation against co-registered 4D flow MRI showed close agreement between flow velocities derived from automated and manual labels, with no significant differences. Conclusion: The proposed framework delivers a scalable, accurate, and uncertainty-aware solution for intracranial artery labeling. By integrating uncertainty quantification, it offers a transparent and clinically trustworthy tool to facilitate cerebrovascular imaging workflows and support subsequent hemodynamic analyses.
- Open Access
- 1 January 2026
- Published by Wiley in Clinical Neuroimaging
- Vol. 3 (1) , e70089
Case Report: Dynamic Fusiform MCA Aneurysm in Culture‐Negative Endocarditis and DRESS Syndrome: Infectious Aneurysm or Superimposed Immuno‐Inflammatory Arteriopathy?
A 37‐year‐old woman with reported beta‐thalassemia minor presented with right Sylvian subarachnoid hemorrhage after several weeks of fever of unknown origin while receiving antibiotic therapy. Initial catheter angiography demonstrated right middle cerebral artery (MCA) branch occlusion without aneurysm; repeat imaging 1 week later demonstrated a dynamic distal right MCA fusiform aneurysm with circumferential vessel wall enhancement and adjacent cerebritis. Echocardiography revealed aortic valve vegetation, but blood cultures, plasma microbial cell‐free DNA testing, and CSF metagenomics were negative throughout her hospitalization. The cerebral aneurysm was managed as a culture‐negative infectious aneurysm, but parent vessel sacrifice was deferred because functional MRI demonstrated bihemispheric language representation and there was a pre‐existing adjacent MCA branch occlusion. Her course was complicated by DRESS syndrome (suspected culprit: vancomycin), accompanied by cervical lymph node histiocytic necrotizing lymphadenitis with Kikuchi‐Fujimoto‐disease‐like features, prompting immunosuppression. Following DRESS‐directed corticosteroid therapy, follow‐up brain MRI and MR angiography (MRA) showed inflammatory changes and aneurysm remodeling and improvement in adjacent cerebral edema. This case illustrates the diagnostic and management overlap between culture‐negative infectious arteritis and a possible superimposed immuno‐inflammatory arteriopathy in the setting of DRESS‐associated hyperinflammation, highlighting the need for serial brain MRI and MRA, MR vessel‐wall imaging, and multidisciplinary decision‐making.
- 1 January 2026
- Published by Wiley in Clinical Neuroimaging
- Vol. 3 (1) , e70089
Open AccessCase Report: Dynamic Fusiform MCA Aneurysm in Culture‐Negative Endocarditis and DRESS Syndrome: Infectious Aneurysm or Superimposed Immuno‐Inflammatory Arteriopathy?
A 37‐year‐old woman with reported beta‐thalassemia minor presented with right Sylvian subarachnoid hemorrhage after several weeks of fever of unknown origin while receiving antibiotic therapy. Initial catheter angiography demonstrated right middle cerebral artery (MCA) branch occlusion without aneurysm; repeat imaging 1 week later demonstrated a dynamic distal right MCA fusiform aneurysm with circumferential vessel wall enhancement and adjacent cerebritis. Echocardiography revealed aortic valve vegetation, but blood cultures, plasma microbial cell‐free DNA testing, and CSF metagenomics were negative throughout her hospitalization. The cerebral aneurysm was managed as a culture‐negative infectious aneurysm, but parent vessel sacrifice was deferred because functional MRI demonstrated bihemispheric language representation and there was a pre‐existing adjacent MCA branch occlusion. Her course was complicated by DRESS syndrome (suspected culprit: vancomycin), accompanied by cervical lymph node histiocytic necrotizing lymphadenitis with Kikuchi‐Fujimoto‐disease‐like features, prompting immunosuppression. Following DRESS‐directed corticosteroid therapy, follow‐up brain MRI and MR angiography (MRA) showed inflammatory changes and aneurysm remodeling and improvement in adjacent cerebral edema. This case illustrates the diagnostic and management overlap between culture‐negative infectious arteritis and a possible superimposed immuno‐inflammatory arteriopathy in the setting of DRESS‐associated hyperinflammation, highlighting the need for serial brain MRI and MRA, MR vessel‐wall imaging, and multidisciplinary decision‐making.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (1)
Technical Performance and Interpretation of Digital Subtraction Angiography to Determine Cerebral Circulatory Arrest in Patients Being Evaluated for Brain Death/Death by Neurological Criteria: A Brief Practice Update From the Society of Vascular and Interventional Neurology (SVIN)
BACKGROUND: The Society of Vascular and Interventional Neurology (SVIN) Guidelines and Practice Standards Committee issues Brief Practice Updates to provide concise, evidence-based recommendations and suggestions on focused topics relevant to vascular and interventional neurology. Currently, there is limited published guidance on the technical performance and interpretative parameters of cerebral digital subtraction angiography for the determination of cerebral circulatory arrest in patients being evaluated for brain death/death by neurological criteria. In this Brief Practice Update, we present consensus-based suggestions for standardizing the performance, interpretation, and application of digital subtraction angiography in this context. METHODS: This Brief Practice Update was developed using the SVIN Standards and Parameters for Guideline Development in the classification of evidence and Class of Recommendation when evidence is available and Expert Opinion recommendation when evidence is lacking. The Guidelines and Practice Standards committee convened a multidisciplinary writing group to establish key clinical questions and develop a survey assessing Expert Opinion on the role of digital subtraction angiography in cerebral circulatory arrest determination. Survey items addressed technical considerations, interpretation criteria, and clinical integration. Iterative refinement was achieved through group consensus, and the final survey was distributed to a panel of experts in neurointervention and neurocritical care. The SVIN Guidelines and Practice Standards Quality Committee reviewed the findings for adherence to SVIN’s internal evidence evaluation guidelines before submission to the SVIN board for societal endorsement. RESULTS: Evidence was evaluated by the writing group when available, and Expert Opinion was assessed using survey results. Suggested recommendations follow the established SVIN guideline framework for Class of Recommendation and Level of Evidence, with an Expert Opinion endorsement category for areas lacking high-quality evidence at the time of publication. CONCLUSIONS: This update standardizes how to perform, interpret, and report digital subtraction angiography when used to assess cerebral circulatory arrest in brain death/death by neurological criteria evaluations, aiming to improve reproducibility across centers. It provides a structured framework to improve consistency and reliability among practitioners performing and interpreting cerebral angiography in this setting.
- 1 January 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (1)
Open AccessTechnical Performance and Interpretation of Digital Subtraction Angiography to Determine Cerebral Circulatory Arrest in Patients Being Evaluated for Brain Death/Death by Neurological Criteria: A Brief Practice Update From the Society of Vascular and Interventional Neurology (SVIN)
BACKGROUND: The Society of Vascular and Interventional Neurology (SVIN) Guidelines and Practice Standards Committee issues Brief Practice Updates to provide concise, evidence-based recommendations and suggestions on focused topics relevant to vascular and interventional neurology. Currently, there is limited published guidance on the technical performance and interpretative parameters of cerebral digital subtraction angiography for the determination of cerebral circulatory arrest in patients being evaluated for brain death/death by neurological criteria. In this Brief Practice Update, we present consensus-based suggestions for standardizing the performance, interpretation, and application of digital subtraction angiography in this context. METHODS: This Brief Practice Update was developed using the SVIN Standards and Parameters for Guideline Development in the classification of evidence and Class of Recommendation when evidence is available and Expert Opinion recommendation when evidence is lacking. The Guidelines and Practice Standards committee convened a multidisciplinary writing group to establish key clinical questions and develop a survey assessing Expert Opinion on the role of digital subtraction angiography in cerebral circulatory arrest determination. Survey items addressed technical considerations, interpretation criteria, and clinical integration. Iterative refinement was achieved through group consensus, and the final survey was distributed to a panel of experts in neurointervention and neurocritical care. The SVIN Guidelines and Practice Standards Quality Committee reviewed the findings for adherence to SVIN’s internal evidence evaluation guidelines before submission to the SVIN board for societal endorsement. RESULTS: Evidence was evaluated by the writing group when available, and Expert Opinion was assessed using survey results. Suggested recommendations follow the established SVIN guideline framework for Class of Recommendation and Level of Evidence, with an Expert Opinion endorsement category for areas lacking high-quality evidence at the time of publication. CONCLUSIONS: This update standardizes how to perform, interpret, and report digital subtraction angiography when used to assess cerebral circulatory arrest in brain death/death by neurological criteria evaluations, aiming to improve reproducibility across centers. It provides a structured framework to improve consistency and reliability among practitioners performing and interpreting cerebral angiography in this setting.
- 1 September 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (9) , 2386-2397
Randomized, Proof-of-Concept Trial (RESCUE) of RNS60 as an Adjunct Therapy in Acute Ischemic Stroke
BACKGROUND: Despite significant improvements in early reperfusion, many patients with acute ischemic stroke with large vessel occlusion experience poor outcomes, which indicates a clear need for adjunct therapies. RNS60 is a proprietary combination of oxygen supersaturated in saline with cerebroprotective and immunomodulatory effects. RNS60 showed therapeutic promise in rodent and nonhuman primate models of acute ischemic stroke. RESCUE (A Randomized, Blinded, Placebo-controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy) was the proof-of-concept trial testing adjunctive treatment with RNS60 in patients with acute ischemic stroke with large vessel occlusion undergoing endovascular thrombectomy with or without prior treatment with an intravenous thrombolytic. METHODS: This randomized multicenter, placebo-controlled, double-blind, phase 2 study enrolled 82 participants, assigned 1:1:1 to 48-hour infusion of RNS60 0.5 mL/kg per hour, RNS60 1.0 mL/kg per hour, or placebo 1.0 mL/kg per hour, and followed for 90 days. Rates of serious adverse events and mortality were the primary end points. Efficacy end points included the modified Rankin Scale score, infarct volume growth, National Institutes of Health Stroke Scale, worsening of stroke, Barthel Index, and the EuroQoL health-related quality of life scale. RESULTS: The RNS60 groups met the primary end points with similar rates of serious adverse events (33.3%, 25.0%, and 28.6%) and fewer deaths (6.7%, 8.3%, and 14.3%) across RNS60 0.5 mL/kg per hour, RNS60 1.0 mL/kg per hour, and placebo, respectively. The RNS60 1.0 mL/kg per hour group showed reduced infarct growth by 47% at 48 hours post–endovascular thrombectomy (21.4 mL [interquartile range, 5.0–29.1] versus 40.6 mL [interquartile range, 6.3–62.3]; P <0.05). No statistically significant differences were observed in other efficacy end points, but a higher proportion of participants in the RNS60 1.0 mL/kg per hour group had reduced disability (modified Rankin Scale score of 0–2) and functional independence (Barthel Index ≥95) on Day 90. CONCLUSIONS: RNS60 was safe and well tolerated. The RNS60 1.0 mL/kg per hour reduced infarct growth after endovascular thrombectomy compared with placebo. This suggests a benefit warranting investigation in a larger, appropriately powered trial. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04693715.
- 1 September 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (9) , 2386-2397
Randomized, Proof-of-Concept Trial (RESCUE) of RNS60 as an Adjunct Therapy in Acute Ischemic Stroke
BACKGROUND: Despite significant improvements in early reperfusion, many patients with acute ischemic stroke with large vessel occlusion experience poor outcomes, which indicates a clear need for adjunct therapies. RNS60 is a proprietary combination of oxygen supersaturated in saline with cerebroprotective and immunomodulatory effects. RNS60 showed therapeutic promise in rodent and nonhuman primate models of acute ischemic stroke. RESCUE (A Randomized, Blinded, Placebo-controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy) was the proof-of-concept trial testing adjunctive treatment with RNS60 in patients with acute ischemic stroke with large vessel occlusion undergoing endovascular thrombectomy with or without prior treatment with an intravenous thrombolytic. METHODS: This randomized multicenter, placebo-controlled, double-blind, phase 2 study enrolled 82 participants, assigned 1:1:1 to 48-hour infusion of RNS60 0.5 mL/kg per hour, RNS60 1.0 mL/kg per hour, or placebo 1.0 mL/kg per hour, and followed for 90 days. Rates of serious adverse events and mortality were the primary end points. Efficacy end points included the modified Rankin Scale score, infarct volume growth, National Institutes of Health Stroke Scale, worsening of stroke, Barthel Index, and the EuroQoL health-related quality of life scale. RESULTS: The RNS60 groups met the primary end points with similar rates of serious adverse events (33.3%, 25.0%, and 28.6%) and fewer deaths (6.7%, 8.3%, and 14.3%) across RNS60 0.5 mL/kg per hour, RNS60 1.0 mL/kg per hour, and placebo, respectively. The RNS60 1.0 mL/kg per hour group showed reduced infarct growth by 47% at 48 hours post–endovascular thrombectomy (21.4 mL [interquartile range, 5.0–29.1] versus 40.6 mL [interquartile range, 6.3–62.3]; P <0.05). No statistically significant differences were observed in other efficacy end points, but a higher proportion of participants in the RNS60 1.0 mL/kg per hour group had reduced disability (modified Rankin Scale score of 0–2) and functional independence (Barthel Index ≥95) on Day 90. CONCLUSIONS: RNS60 was safe and well tolerated. The RNS60 1.0 mL/kg per hour reduced infarct growth after endovascular thrombectomy compared with placebo. This suggests a benefit warranting investigation in a larger, appropriately powered trial. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04693715.
- 1 July 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (1) , 1-8
A Report from the Inaugural Society of NeuroInterventional Surgery Neurointerventional Oncology Summit
BACKGROUND: Over the past 25-years, progress in the treatment of central nervous system (CNS) tumors has been limited and outcomes for malignancies such as glioblastoma and diffuse intrinsic pontine glioma remain dismal. There has been great interest in harnessing endovascular neurointerventional techniques and to use the cerebral vasculature as a route for therapeutic delivery in neuro-oncology. Several selective intra-arterial clinical trials are currently underway targeting a range of CNS tumors with different therapeutic agents. METHODS: The Society of NeuroInterventional Surgery (SNIS) convened the inaugural Neurointerventional Oncology Summit which was held on April 26-27, 2024, at the University of Texas MD Anderson Cancer Center in Houston, Texas. The group consisted of neuro-interventionists, neurosurgeons, neuro-oncologists, neuroradiologists, basic scientists and industry representatives who are current practitioners in this emerging space. We report the current state of practice and our efforts to develop an organizational platform to treat patients suffering from CNS cancers and to advance research in this emerging field. KEY MESSAGE: Endovascular surgical neuro-oncology is an emerging clinical endeavor which aims to provide novel therapeutic options for CNS cancers. Novel therapeutic agents including yttrium-90, oncolytic viruses and cellular immunotherapy are being tested as intraarterial therapy. Technological advances in imaging modalities, selective methods of blood brain barrier opening, and devices and catheters will aid advancement of the field. Multi-disciplinary cooperation and collaboration will be integral to the success of this endeavor. ABBREVIATIONS: BBB = blood brain barrier; CAR = chimeric antigen receptor; DIPG = diffuse intrinsic pontine glioma; ESIA = endovascular selective intra-arterial; ESSIA = endovascular super-selective intra-arterial; FUS = focused ultrasound; GBM = glioblastoma; MSC-D24 = delta 24 oncolytic virus in mesenchymal stem cell; NK = natural killer; Y-90 = yttrium-90
- 1 July 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (1) , 1-8
A Report from the Inaugural Society of NeuroInterventional Surgery Neurointerventional Oncology Summit
BACKGROUND: Over the past 25-years, progress in the treatment of central nervous system (CNS) tumors has been limited and outcomes for malignancies such as glioblastoma and diffuse intrinsic pontine glioma remain dismal. There has been great interest in harnessing endovascular neurointerventional techniques and to use the cerebral vasculature as a route for therapeutic delivery in neuro-oncology. Several selective intra-arterial clinical trials are currently underway targeting a range of CNS tumors with different therapeutic agents. METHODS: The Society of NeuroInterventional Surgery (SNIS) convened the inaugural Neurointerventional Oncology Summit which was held on April 26-27, 2024, at the University of Texas MD Anderson Cancer Center in Houston, Texas. The group consisted of neuro-interventionists, neurosurgeons, neuro-oncologists, neuroradiologists, basic scientists and industry representatives who are current practitioners in this emerging space. We report the current state of practice and our efforts to develop an organizational platform to treat patients suffering from CNS cancers and to advance research in this emerging field. KEY MESSAGE: Endovascular surgical neuro-oncology is an emerging clinical endeavor which aims to provide novel therapeutic options for CNS cancers. Novel therapeutic agents including yttrium-90, oncolytic viruses and cellular immunotherapy are being tested as intraarterial therapy. Technological advances in imaging modalities, selective methods of blood brain barrier opening, and devices and catheters will aid advancement of the field. Multi-disciplinary cooperation and collaboration will be integral to the success of this endeavor. ABBREVIATIONS: BBB = blood brain barrier; CAR = chimeric antigen receptor; DIPG = diffuse intrinsic pontine glioma; ESIA = endovascular selective intra-arterial; ESSIA = endovascular super-selective intra-arterial; FUS = focused ultrasound; GBM = glioblastoma; MSC-D24 = delta 24 oncolytic virus in mesenchymal stem cell; NK = natural killer; Y-90 = yttrium-90
- Open Access
- 4 April 2025
- Published by The Royal Society in Interface Focus
- Vol. 15 (1) , 20240040
Non-invasive quantification of pressure drops in stenotic intracranial vessels: using deep learning-enhanced 4D flow MRI to characterize the regional haemodynamics of the pulsing brain
Stenosis of major intracranial arteries is a significant cause of stroke, with assessment of trans-stenotic pressure drops being a key marker of functional stenosis severity. Non-invasive methods for quantifying intracranial pressure changes are hence crucial; however, the narrow and tortuous cerebrovascular network poses challenges to traditional assessment methods such as transcranial Doppler. This study investigates the use of novel deep learning-enhanced super-resolution (SR) four-dimensional (4D) flow magnetic resonance imaging (MRI) in combination with a physics-informed virtual work–energy relative pressure technique to quantify pressure drops across stenotic intracranial arteries. Performance was validated in intracranial-mimicking in vitro experiments using pulsatile flow before being transferred into an in vivo cohort of patients with intracranial atherosclerotic disease. Conversion into sub-millimetre SR imaging significantly improved the accuracy of regional relative pressure estimations in the pulsing brain arteries, mitigating biases observed at >1 mm resolution imaging, and agreeing strongly with reference catheter-based invasive measurements across both moderate and severe stenoses. The in vivo analysis also revealed a significant increase in pressure drops when converting into sub-millimetre SR data, underlining the importance of apparent image resolution in a clinical setting. The results highlight the potential of SR 4D flow MRI for non-invasive quantification of cerebrovascular pressure changes in pulsing intracranial arteries across stenotic vessel segments.
- 4 April 2025
- Published by The Royal Society in Interface Focus
- Vol. 15 (1) , 20240040
Open AccessNon-invasive quantification of pressure drops in stenotic intracranial vessels: using deep learning-enhanced 4D flow MRI to characterize the regional haemodynamics of the pulsing brain
Stenosis of major intracranial arteries is a significant cause of stroke, with assessment of trans-stenotic pressure drops being a key marker of functional stenosis severity. Non-invasive methods for quantifying intracranial pressure changes are hence crucial; however, the narrow and tortuous cerebrovascular network poses challenges to traditional assessment methods such as transcranial Doppler. This study investigates the use of novel deep learning-enhanced super-resolution (SR) four-dimensional (4D) flow magnetic resonance imaging (MRI) in combination with a physics-informed virtual work–energy relative pressure technique to quantify pressure drops across stenotic intracranial arteries. Performance was validated in intracranial-mimicking in vitro experiments using pulsatile flow before being transferred into an in vivo cohort of patients with intracranial atherosclerotic disease. Conversion into sub-millimetre SR imaging significantly improved the accuracy of regional relative pressure estimations in the pulsing brain arteries, mitigating biases observed at >1 mm resolution imaging, and agreeing strongly with reference catheter-based invasive measurements across both moderate and severe stenoses. The in vivo analysis also revealed a significant increase in pressure drops when converting into sub-millimetre SR data, underlining the importance of apparent image resolution in a clinical setting. The results highlight the potential of SR 4D flow MRI for non-invasive quantification of cerebrovascular pressure changes in pulsing intracranial arteries across stenotic vessel segments.
- Open Access
- 13 November 2024
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 3 (4) , 407-418
Cerebral Arterial Inflow and Venous Outflow Assessment Using 4D Flow MRI in Adult and Pediatric Patients
Background and Purpose: The cerebral circulation is highly regulated to maintain brain perfusion, keeping an equilibrium between the brain tissue, cerebrospinal fluid (CSF) and blood of the arterial and venous systems. Cerebral venous drainage abnormalities have been implicated in multiple cerebrovascular diseases. The purpose of this study is to evaluate the relationship between the arterial inflow (AI) and the cerebral venous outflow (CVO) and their correlation with the cardiac outflow in healthy adults and children to understand the role of the emissary veins in normal venous drainage. Materials and Methods: A total of 31 healthy volunteers (24 adults (39.5 ± 16.0) and seven children (3.4 ± 2.2)) underwent intracranial 4D flow with full circle of Willis coverage and 2D PC-MRI at the level of the transverse sinus for measurement of the AI and CVO, respectively. The AI was calculated as the sum of the flow values in the bilateral internal carotid and basilar arteries. The CVO was calculated as the sum of the flow values in the bilateral transverse sinuses. The cardiac outflow was measured via 2D PC-MRI with retrospective ECG gating with images acquired at the proximal ascending aorta (AAo) and descending (DAo) aorta. The ratios of the AI/AAo flow and CVO/AI were calculated to characterize the fraction of cerebral arterial inflow in relation to cardiac outflow and venous blood draining through the transverse sinuses, respectively. Results: The AI and CVO were significantly correlated (r = 0.81, p < 0.001). The CVO constituted approximately 60–70% of the AI. The CVO/AI ratio was significantly lower in children versus adults (p = 0.025). In adults, the negative correlation of the AI with age remained strong (r = −0.81, p < 0.001). However, the CVO was not significantly associated with age. Conclusion: The CVO/AI ratio suggests an important role of the emissary veins, accounting for approximately 30–40% of venous drainage. The lower CVO/AI ratio in children, although partially related to decreased AI with age, suggests a greater role of the emissary veins in childhood, which strongly decreases with age.
- 13 November 2024
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 3 (4) , 407-418
Open AccessCerebral Arterial Inflow and Venous Outflow Assessment Using 4D Flow MRI in Adult and Pediatric Patients
Background and Purpose: The cerebral circulation is highly regulated to maintain brain perfusion, keeping an equilibrium between the brain tissue, cerebrospinal fluid (CSF) and blood of the arterial and venous systems. Cerebral venous drainage abnormalities have been implicated in multiple cerebrovascular diseases. The purpose of this study is to evaluate the relationship between the arterial inflow (AI) and the cerebral venous outflow (CVO) and their correlation with the cardiac outflow in healthy adults and children to understand the role of the emissary veins in normal venous drainage. Materials and Methods: A total of 31 healthy volunteers (24 adults (39.5 ± 16.0) and seven children (3.4 ± 2.2)) underwent intracranial 4D flow with full circle of Willis coverage and 2D PC-MRI at the level of the transverse sinus for measurement of the AI and CVO, respectively. The AI was calculated as the sum of the flow values in the bilateral internal carotid and basilar arteries. The CVO was calculated as the sum of the flow values in the bilateral transverse sinuses. The cardiac outflow was measured via 2D PC-MRI with retrospective ECG gating with images acquired at the proximal ascending aorta (AAo) and descending (DAo) aorta. The ratios of the AI/AAo flow and CVO/AI were calculated to characterize the fraction of cerebral arterial inflow in relation to cardiac outflow and venous blood draining through the transverse sinuses, respectively. Results: The AI and CVO were significantly correlated (r = 0.81, p < 0.001). The CVO constituted approximately 60–70% of the AI. The CVO/AI ratio was significantly lower in children versus adults (p = 0.025). In adults, the negative correlation of the AI with age remained strong (r = −0.81, p < 0.001). However, the CVO was not significantly associated with age. Conclusion: The CVO/AI ratio suggests an important role of the emissary veins, accounting for approximately 30–40% of venous drainage. The lower CVO/AI ratio in children, although partially related to decreased AI with age, suggests a greater role of the emissary veins in childhood, which strongly decreases with age.